296 to 310
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Blocking - Blocking peptide for Anti-FSD1 antibody (
Concentration information loading... 前処理および保存
Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
Fibronectin type 3 and SPRY (spla, ryanodine) domain containing (with coiled-coil motif) 1
Fibronectin type 3 and SPRY domain containing 1
Fibronectin type III and SPRY domain containing 1
May be involved in microtubule organization and stabilization.
Highly expressed in brain tissues, including cerebellum, cerebral cortex, medulla, occipital pole, frontal lobe, temporal lobe and putamen. Lower expression in spinal chord.
Contains 1 B30.2/SPRY domain.
Contains 1 COS domain. Contains 1 fibronectin type-III domain.
B30.2 box contains a microtubule-binding site.
Cytoplasm > cytoskeleton > centrosome. Nucleus. Cytoplasm. Cleavage furrow. Cell-cycle-dependent association with the centrosome. Colocalizes with a subpopulation of microtubules. Does not associates with microtubules during mitosis but reassociates with microtubules during cytokinesis. Localizes to the central portions of a small subset of microtubules in interphase cells and a subpopulation of microtubules in the cleavage furrow, not present in the mitotic spindle.
Information by UniProt
FSD1 peptide (296-310) (ab45845) 使用論文
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"